Todd Anderman, Chief Legal Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 22,264 shares at $12.34 ($275K) on 2025-10-08, disclosed to the SEC on 2025-10-10.
Scheduled sale ($275k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.34 | 11,132 | $137K | 50.0% |
| 2 | $12.34 | 11,132 | $137K | 50.0% |
| Total | $12.34 avg | 22,264 | $275K | 100% |